Page last updated: 2024-09-05

farglitazar and quinazolines

farglitazar has been researched along with quinazolines in 1 studies

Compound Research Comparison

Studies (farglitazar)	Trials (farglitazar)	Recent Studies (post-2010) (farglitazar)	Studies (quinazolines)	Trials (quinazolines)	Recent Studies (post-2010) (quinazolines)
35	3	5	19,235	2,417	8,835

Protein Interaction Comparison

Protein	Taxonomy	farglitazar (IC50)	quinazolines (IC50)
Epidermal growth factor receptor	Homo sapiens (human)		0.027

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Byrjalsen, I; Christiansen, C; Gardner, S; Goodman, Z; Henriksen, K; Karsdal, MA; Krag, A; Leeming, DJ; Nielsen, MJ; Patel, K; Schuppan, D	1

Trials

1 trial(s) available for farglitazar and quinazolines

Article	Year
Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapy. American journal of physiology. Gastrointestinal and liver physiology, 2016, 12-01, Volume: 311, Issue:6 Topics: Biomarkers; Collagen Type III; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Oxazoles; Patient Selection; Quinazolines; Thiazolidinediones; Tyrosine	2016

Article

Year

Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapy.

American journal of physiology. Gastrointestinal and liver physiology, 2016, 12-01, Volume: 311, Issue:6

Topics: Biomarkers; Collagen Type III; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Oxazoles; Patient Selection; Quinazolines; Thiazolidinediones; Tyrosine

2016